MarginsXMarginsX
Home › Markets › Health Care › MDXH

MDxHealth SA (MDXH)

MDXH trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.1490
+3.40% on the day
Market cap
$14.2M
Nano cap
Revenue · 2025
$107.9M
+19.8% on 2024
Net income · 2025
-$33.5M
-31.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1872529/000121390026039540/0001213900-26-039540-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMDXH on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryBelgium
IPO year2021
SEC CIK0001872529
SEC industry codeServices-Medical Laboratories
Incorporated inBelgium

Financials · 2025

LineValue
Revenue$107.9M
Net income-$33.5M
Operating income-$14.4M
Net margin-31.1%
Operating margin-13.4%
Revenue growth+19.8%
Cash$29.0M
Total assets$148.0M
P/E (computed)Net income was not positive
P/S (computed)0.1×

Warning signs

Cash runway
159.2 months
$29.0M cash at December 31, 2025
Share count, 1 year
+3.8%
2024-12-31 to 2025-12-31
Going-concern doubt
Yes
20-F filed April 3, 2026
Insider net buying, 12 months
$991K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As discussed in Note 2.3 to the consolidated financial statements, the Company has suffered recurring losses from operations and expects to incur significant cash outflows for at least the next twelve months that raise substantial doubt about its ability to continue as a going concern."
20-F 2026-04-03
Cash and burn$29.0M cash; operating cash flow -$547K a quarter.Report 2025-12-31
Shares outstanding51,364,520 (2025-12-31); 49,497,334 a year earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-08-13
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises, Zaventem, BelgiumPCAOB Form AP 2026-04-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $991K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 95,417,377 shares at the 2026-11-13 price; the latest SEC cover count is 51,364,520 as of 2025-12-31. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$107.9M-$33.5M-$2.2M$29.0M$76.2M$107.9M20-F 2026-04-03
FY 2024
2024-12-31
$90.0M-$38.1M-$18.5M$46.8M$51.0M$90.0M20-F 2026-04-03
FY 2023
2023-12-31
$70.2M-$43.1M-$21.5M$22.4M$35.6M$70.2M20-F 2026-04-03
FY 2022
2022-12-31
$37.1M-$44.0M-$34.1M$15.5M$34.9M$37.1M20-F 2025-03-31
FY 2021
2021-12-31
$22.2M-$29.0M-$22.5M$58.5MNo debt tags$22.2M20-F 2024-04-30
FY 2020
2020-12-31
$18.5M-$28.7M-$20.2M$16.0MNo debt tags$18.5M20-F 2023-04-25
FY 2019
2019-12-31
$11.8M-$43.1M-$22.3MNot filedNo debt tags$11.8M20-F 2022-04-25

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-08-13
Latest annual report
ANNUAL REPORT
20-F2026-04-03
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-12

Source: SEC EDGAR submissions feed, 185 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-8.3%
1 month-78.2%
3 months-68.8%
Year to date-96.0%
1 year-96.4%
From 52-week high-96.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
AMSAmerican Shared Hospital Services$1.07-0.93%$7.1M
ACHAccendra Health Inc.$0.0857-35.08%$6.6M
ACONAclarion Inc.$1.39-12.58%$4.0M
ADVBAdvanced Biomed Inc.$2.22-12.25%$3.7M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
BGLCBioNexus Gene Lab Corp$0.8200-0.12%$2.4M
XGNExagen Inc.$3.77-8.72%$96.2M
BDSXBiodesix Inc.$9.00-8.91%$99.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier